Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.
about
Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancerFrom bench to bedside a comprehensive review of pancreatic cancer immunotherapy.Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reactionMyeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentInflammatory networks and immune surveillance of pancreatic carcinomaMyeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implicationsPro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic TargetsThe Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionThe tumor microenvironment in esophageal cancerImmunosuppression associated with chronic inflammation in the tumor microenvironmentThe emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironmentMacrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment.Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer.Vaccine-induced myeloid cell population dampens protective immunity to SIVImmunotherapy for solid tumors--a review for surgeons.The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques.Expansion of myeloid-derived suppressor cells from peripheral blood decreases after 4-week antiviral treatment in patients with chronic hepatitis C.Chemotherapy and tumor microenvironment of pancreatic cancer.Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016.Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes.Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesInfiltration of alternatively activated macrophages in cancer tissue is associated with MDSC and Th2 polarization in patients with esophageal cancer.Bioactive compounds or metabolites from black raspberries modulate T lymphocyte proliferation, myeloid cell differentiation and Jak/STAT signaling.Complex role for the immune system in initiation and progression of pancreatic cancer.p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responsesMyeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patientsThe immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells.Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study.A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patientsIncreased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemiaDiscovering the route from inflammation to pancreatic cancer.Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality.B cells promote tumor progression via STAT3 regulated-angiogenesisComparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3.Myxomaviral Anti-Inflammatory Serpin Reduces Myeloid-Derived Suppressor Cells and Human Pancreatic Cancer Cell Growth in MicePresence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients.
P2860
Q26740208-60B50CE8-71F1-4200-B4AD-080D9C679E3EQ26765123-CE7D3F55-4F75-4FC0-B5E1-466AF592FB74Q26777542-4AE687FD-2D15-40A0-BE67-C570622F7C8FQ26799126-9D6BF5CB-EE37-416B-99AA-3CA0CE0B9E75Q27013983-DB8C5E62-4B38-4337-9D0B-342174B9BD8FQ27014189-BAAE4D24-77C6-4CD4-B8A7-A50CF7E1AF01Q28076161-8A1300ED-DF8D-4FDF-9730-ABEFDA3ABB6AQ28076760-138558D9-25F8-4FBA-BA10-33A54CD5CDE8Q28077074-79E0F979-8299-4A84-9866-BDDCEBED4C5BQ28083450-1AC71F9B-1344-48DC-AB5B-8FEF7341E76FQ28396481-7DE113F6-9C88-422A-A470-5F5D248FB6D1Q30415763-B9E9572B-B1A2-46FB-8C2F-6365AACBD7B2Q33560501-F4F5E4E9-F94E-4A06-9A47-BFAA13630E7CQ33606107-F5C620F5-60D8-4D92-A393-A8E9E0A819FEQ33685961-2C07B9CA-3AAF-432F-8341-A6BF99005F29Q33709232-E99F88CE-9FFF-42B1-97C7-80F56B81E97BQ33709243-EC3E2BE4-9FE6-42BA-8E20-023D182E0350Q33739465-5B99934A-5184-4FDC-970A-E7C5963032BAQ33756291-D377C191-02A6-4419-B907-43864A2130F5Q33876637-9BDA76F7-C500-42C0-B57F-BD0EF8F580D0Q33913101-4E812F20-DD2D-417F-80E4-5BCB203CAAF0Q34016867-9A46443B-EDCC-4B6F-865D-6DEED0C6536DQ34044797-040875FD-9C41-49E0-82A4-4FE7278DB529Q34075192-8BFBE707-D6D1-4CA8-A6DA-A97E5798CABAQ34079557-F37A8425-3B06-4FEB-AE05-C5B5B33BDEBFQ34093784-BDF28087-160B-4A1F-829C-516F9CB5B943Q34135426-C3FFB02B-8BA5-4675-9129-882AFBB6FB53Q34250873-B2AD4EB5-16CA-4229-9662-0889BC03C37FQ34315871-0637CB05-74A2-40BB-A3D8-348726862952Q34483744-707E2DD0-A08A-45A8-AE99-DF126361487CQ34486464-D80D2527-146E-4E13-97CE-52049C47ABC5Q34566554-C56ED5B2-7B8C-4D3A-A78E-0B0C0E8CD382Q34570094-38B576B4-8FA7-4A15-B189-7AE877787648Q34576982-350C5344-C2B3-484A-8F74-F9695D9CB91DQ34645978-68A2BB33-8F73-4ABE-9CFC-4BCF33EE485AQ34648541-EDC6DB85-0BB3-487D-8A30-814B3F2A06E0Q34755398-DD4C3E7A-E04E-47C1-96BA-DA43CBC5985FQ35195777-93229C5A-AE90-46C1-86FF-3CFCD579F87BQ35200102-ACE9D000-835D-4EA8-803A-9A6631957BD5Q35225664-A8EA358D-300C-458A-BA7B-12FBF17FCFA7
P2860
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Elevated myeloid-derived suppr ...... e Th2 cytokine interleukin-13.
@ast
Elevated myeloid-derived suppr ...... e Th2 cytokine interleukin-13.
@en
type
label
Elevated myeloid-derived suppr ...... e Th2 cytokine interleukin-13.
@ast
Elevated myeloid-derived suppr ...... e Th2 cytokine interleukin-13.
@en
prefLabel
Elevated myeloid-derived suppr ...... e Th2 cytokine interleukin-13.
@ast
Elevated myeloid-derived suppr ...... e Th2 cytokine interleukin-13.
@en
P2093
P2860
P1476
Elevated myeloid-derived suppr ...... e Th2 cytokine interleukin-13.
@en
P2093
Deborah D Stocken
Gary W Middleton
Hardev A Pandha
Nicola E Annels
Rachel F Gabitass
P2860
P2888
P304
P356
10.1007/S00262-011-1028-0
P577
2011-06-05T00:00:00Z